In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Help Wanted: FDA's Office Of Regulatory Affairs Looks To Plug Investigator Vacancies, Begins 'Succession Planning'

Executive Summary

The US FDA's Office of Regulatory Affairs – which handles all of the agency's field activities – is "sitting on a lot of vacancies right now," FDA official Jan Welch said at MedCon 2019. Here's what ORA wants to do to nab and retain staff, and plan for the next generation of senior supervisors.

You may also be interested in...

'Program Alignment' Turns 1: FDA Wants To Train Investigators On Innovative Tech As Part Of Its Inspection Scheme – But Will It Be A Cakewalk?

At the one-year anniversary of "program alignment" – US FDA's ambitious reorganization of its inspectional body – the agency is pushing hard to train its investigators on an array of medtech products. In that spirit, FDA has asked manufacturers to willingly open their doors to its investigators so they can learn more about the type of devices the firms are making, says Blake Bevill, a program division director for program alignment. Industry group AdvaMed and health-care organization Medical Alley Association are also getting in on the action by helping investigators learn about an array of topics, including software, electrical engineering, validation and design.

'Program Alignment' Snaps Together: What's Next For US FDA's Inspection Scheme

Almost six months into its new "program alignment" inspection approach, FDA's initiative to inspect along commodity lines is still gaining its sea legs. A key FDA official says the agency is taking steps to train and retain specialized investigators. Meanwhile, FDA wants to use a geographic information system (GIS) tool to keep tabs on where investigators are inspecting.

US Regulatory Roundup, May 2020: Quality System Reg Redo Delayed (Again); COVID-19 News; CAPA 2.0; And More

News that the US FDA missed its third self-imposed deadline for releasing a draft version of its retooled Quality System Regulation and our ongoing coverage of the coronavirus crisis captured the attention of many of our online readers last month, as did a look at a new way to conduct corrective and preventive action (CAPA) activities. Here are May’s 10 most popular US regulation and policy stories from Medtech Insight.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts